about
Management of High-risk Corneal Transplantation.Boston keratoprosthesis type 1: outcomes of the first 38 cases performed at Moorfields Eye Hospital.The Balance of Th1/Th2 and LAP+Tregs/Th17 Cells Is Crucial for Graft Survival in Allogeneic Corneal Transplantation.Biomaterials-enabled cornea regeneration in patients at high risk for rejection of donor tissue transplantation.The effects of local administration of mesenchymal stem cells on rat corneal allograft rejection.
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
High-risk corneal allografts: A therapeutic challenge
@ast
High-risk corneal allografts: A therapeutic challenge
@en
High-risk corneal allografts: A therapeutic challenge
@nl
type
label
High-risk corneal allografts: A therapeutic challenge
@ast
High-risk corneal allografts: A therapeutic challenge
@en
High-risk corneal allografts: A therapeutic challenge
@nl
prefLabel
High-risk corneal allografts: A therapeutic challenge
@ast
High-risk corneal allografts: A therapeutic challenge
@en
High-risk corneal allografts: A therapeutic challenge
@nl
P2093
P2860
P356
P1476
High-risk corneal allografts: A therapeutic challenge
@en
P2093
John V Forrester
Lucia Kuffová
May Griffith
Vijayalakshmi Rajendran
P2860
P356
10.5500/WJT.V6.I1.10
P407
P577
2016-03-24T00:00:00Z